Search Results (4)

Background: Enterococcus species present significant health risks due to their widespread presence in humans, animals, and the environment. This study examined the patterns of antimicrobial resistance (AMR) and the presence of carbapenemase-producing Enterococcus species from various sources. Methods: Between November 2023 and February 2024, 500 samples were collected in Lagos State, including 350 clinical human samples, 50 environmental samples, and 100 animal samples. The samples were processed, and Enterococcus isolates were identified and subjected to antimicrobial susceptibility tests (AST) by standard methods. Furthermore, carbapenemase (bla_KPC and oxa-48) and virulence genes (gelE) were detected by real-time polymerase chain reaction (RT-PCR) methods using specific primers. Results: The overall prevalence of Enterococcus isolates was 4.6% (23/500), including 18 E. faecalis and 5 E. faecium. The source prevalence was 24% (12/50) from the environmental samples, 5% (5/100) from animal sources, and 1.7% (6/350) from the clinical samples. All Enterococcus isolates were 100% resistant to ciprofloxacin, erythromycin, imipenem, vancomycin, and ampicillin. However, 91% were susceptible to gentamicin. Six (6) distinct resistance profiles were observed, with the pattern AMP-ERY-TGC-CIP-TS-VA-CHL-AUG-MEM-IMI being the most frequent in 12 E. faecalis (4 isolates from humans, 2 from animals, and 6 from the environment). Notably, 39.1% (9/23) of multiple-drug resistant Enterococcus isolates harbored the gelE virulence gene, including seven E. faecalis (five environmental and two human) and two E. faecium from animal sources. The E. faecalis strains HB003 and HB050, from human bacteremia cases carrying gelE, were the first in Nigeria to produce bla_KPC and oxa-48 carbapenemase genes. Conclusions: This study revealed the emergence of carbapenemase-producing Enterococcus species in our environment. A one-health approach and further molecular studies are essential to mitigate the spread and understand the transmission dynamics. Full article

The present article exemplifies the application of the concept of quality by design (QbD) for the systematic development of a nanoparticulate imiquimod (IMQ) emulsion gel formulation as an investigational medicinal product (IMP) for evaluation in an academic phase-I/II clinical trial for the treatment of actinic keratosis (AK) against the comparator Aldara (EudraCT: 2015-002203-28). The design of the QbD elements of a quality target product profile (QTPP) enables the identification of the critical quality attributes (CQAs) of the drug product as the content of IMQ, the particle-size distribution, the pH, the rheological properties, the permeation rate and the chemical, physical and microbiological stability. Critical material attributes (CMAs) and critical process parameters (CPPs) are identified by using a risk-based approach in an Ishikawa diagram and in a risk-estimation matrix. In this study, the identified CPPs of the wet media ball-milling process’s milling time and milling speed are evaluated in a central composite design of experiments (DoEs) approach, revealing criticality for both factors for the resulting mean particle size, while only the milling time is significantly affecting the polydispersity. To achieve a mean particle size in the range of 300–400 nm with a minimal PdI, the optimal process conditions are found to be 650 rpm for 135 min. Validating the model reveals a good correlation between the predicted and observed values. Adequate control strategies were implemented for intermediate products as in-process controls (IPCs) and quality control (QC) tests of the identified CQAs. The IPC and QC data from 13 “IMI-Gel” batches manufactured in adherence to good manufacturing practice (GMP) reveal consistent quality with minimal batch-to-batch variability. Full article

The aim of this study was to characterize the prevalence of fecal carriage of extended-spectrum beta-lactamases and carbapenemase-producing Gram-negative bacteria among healthy humans in Tunisia. Fifty-one rectal swabs of healthy volunteers were plated on MacConkey agar plates supplemented with cefotaxime or imipenem. The occurrences of resistance genes, integrons, and phylogroup typing were investigated using PCR and sequencing. The genetic relatedness of isolates was determined by pulsed-field-gel-electrophoresis (PFGE) and multilocus-sequence-typing (MLST). Whole-genome-sequencing (WGS) was performed for the carbapenem-resistant isolate. Sixteen ESBL-producing Escherichia coli isolates and one carbapenem-resistant Enterobacter bugandensis were detected out of the fifty-one fecal samples. The ESBL-producing E. coli strains contained genes encoding CTX-M-15 (n = 9), CTX-M-1 (n = 3), CTX-M-27 (n = 3), and CTX-M-55 (n = 1). Three CTX-M-1-producers were of lineages ST131, ST7366, and ST1158; two CTX-M-15-producers belonged to lineage ST925 and ST5100; one CTX-M-27-producer belonged to ST2887, and one CTX-M-15-producer belonged to ST744. Six isolates contained class 1 integrons with the following four gene cassette arrangements: dfrA5 (two isolates), dfrA12-orf-aadA2 (two isolates), dfrA17-aadA5 (one isolate), and aadA1 (one isolate). E. bugandensis belonged to ST1095, produced IMI-2 carbapenemase, and contained qnrE1 and fosA genes. A genome-sequence analysis of the E. bugandensis strain revealed new mutations in the bla_ACT and qnr genes. Our results reveal an alarming rate of ESBL-E. coli in healthy humans in Tunisia and the first description of IMI-2 in E. bugandensis. Full article

During the last decades, heterogenous photocatalysis has shown as the most promising advanced oxidation process for the removal of micropollutants due to degradation rate, sustainability, non-toxicity, and low-cost. Synergistic interaction of light irradiation, photocatalysts, and highly reactive species are used to break down pollutants toward inert products. Even though titanium dioxide (TiO₂) is the most researched photocatalyst, to overcome shortcomings, various modifications have been made to intensify photocatalytic activity in visible spectra range among which is modification with multiwalled carbon nanotubes (MWCNTs). Therefore, photocatalytic oxidation and its intensification by photocatalyst’s modification was studied on the example of four micropollutants (diclofenac, DF; imidacloprid, IMI; 1-H benzotriazole, BT; methylene blue, MB) degradation. Compound parabolic collector (CPC) reactor was used as, nowadays, it has been considered the state-of-the-art system due to its usage of both direct and diffuse solar radiation and quantum efficiency. A commercially available TiO₂ P25 and nanocomposite of TiO₂ and MWCNT were immobilized on a glass fiber mesh by sol-gel method. Full-spectra solar lamps with appropriate UVB and UVA irradiation levels were used in all experiments. Photocatalytic degradation of DF, IMI, BT, and MB by immobilized TiO₂ and TiO₂/CNT photocatalysts was achieved. Mathematical modelling which included mass transfer and photon absorption was applied and intrinsic reaction rate constants were estimated: $k_{\mathrm{DF}}=3.56 \times {10}^{-10}{\mathrm{s}}^{-1}{\mathrm{W}}^{-0.5}{\mathrm{m}}^{1.5}$, $k_{\mathrm{IMI}}=8.90 \times {10}^{-11}{\mathrm{s}}^{-1}{\mathrm{W}}^{-0.5}{\mathrm{m}}^{1.5}$, $k_{\mathrm{BT}}=1.20 \times {10}^{-9}{\mathrm{s}}^{-1}{\mathrm{W}}^{-0.5}{\mathrm{m}}^{1.5}$, $k_{\mathrm{MB}}=1.62 \times {10}^{-10}{\mathrm{s}}^{-1}{\mathrm{W}}^{-0.5}{\mathrm{m}}^{1.5}$. Intensification of photocatalysis by TiO₂/CNT was observed for DF, IMI, and MB, while that was not the case for BT. The developed model can be effectively applied for different irradiation conditions which makes it extremely versatile and adaptable when predicting the degradation extents throughout the year using sunlight as the energy source at any location. Full article